OBJECTIVE: To determine whether monocyte/macrophage expression of the CD6 ligand, activated leukocyte cell adhesion molecule (ALCAM) (CD166), is regulated by cytokines during inflammation in rheumatoid arthritis (RA). METHODS: We used flow cytometry to test whether cytokines present in rheumatoid synovium could regulate ALCAM cell surface expression on peripheral blood (PB) monocytes and RA synovial fluid (SF) macrophages, and we examined ALCAM expression in situ in RA synovium by immunofluorescence. RESULTS: The monocyte differentiation factors interleukin-3, macrophage colony-stimulating factor (M-CSF), and granulocyte-macrophage colony-stimulating factor augmented ALCAM expression on PB monocytes. ALCAM was expressed on monocyte-lineage cells in situ in inflamed synovium from patients with RA (9 of 9), but not in uninflamed synovium from patients with joint trauma (0 of 3). Furthermore, in vitro culture-induced ALCAM expression on PB monocytes and CD14+ RA SF cells was inhibited by an M-CSF neutralizing antibody. CONCLUSION: ALCAM expression on PB and SF monocytes/macrophages is enhanced by M-CSF.
OBJECTIVE: To determine whether monocyte/macrophage expression of the CD6 ligand, activated leukocyte cell adhesion molecule (ALCAM) (CD166), is regulated by cytokines during inflammation in rheumatoid arthritis (RA). METHODS: We used flow cytometry to test whether cytokines present in rheumatoid synovium could regulate ALCAM cell surface expression on peripheral blood (PB) monocytes and RA synovial fluid (SF) macrophages, and we examined ALCAM expression in situ in RA synovium by immunofluorescence. RESULTS: The monocyte differentiation factors interleukin-3, macrophage colony-stimulating factor (M-CSF), and granulocyte-macrophage colony-stimulating factor augmented ALCAM expression on PB monocytes. ALCAM was expressed on monocyte-lineage cells in situ in inflamed synovium from patients with RA (9 of 9), but not in uninflamed synovium from patients with joint trauma (0 of 3). Furthermore, in vitro culture-induced ALCAM expression on PB monocytes and CD14+ RA SF cells was inhibited by an M-CSF neutralizing antibody. CONCLUSION:ALCAM expression on PB and SF monocytes/macrophages is enhanced by M-CSF.
Authors: Syed M A Abidi; Mohammad K Saifullah; Marie D Zafiropulos; Cara Kaput; Michael A Bowen; Calvin Cotton; Nora G Singer Journal: J Clin Immunol Date: 2006-01 Impact factor: 8.317
Authors: Xinyan Tang; Liufang Jing; William J Richardson; Robert E Isaacs; Robert D Fitch; Christopher R Brown; Melissa M Erickson; Lori A Setton; Jun Chen Journal: J Orthop Res Date: 2016-04-13 Impact factor: 3.494
Authors: Yan Li; Jeffrey H Ruth; Stephanie M Rasmussen; Kalana S Athukorala; Daniel P Weber; M Asif Amin; Phillip L Campbell; Nora G Singer; David A Fox; Feng Lin Journal: Arthritis Rheumatol Date: 2020-08-14 Impact factor: 10.995
Authors: R Yamada; T Tanaka; M Unoki; T Nagai; T Sawada; Y Ohnishi; T Tsunoda; M Yukioka; A Maeda; K Suzuki; H Tateishi; T Ochi; Y Nakamura; K Yamamoto Journal: Am J Hum Genet Date: 2001-02-14 Impact factor: 11.025
Authors: P C Rodríguez; D M Prada; E Moreno; L E Aira; C Molinero; A M López; J A Gómez; I M Hernández; J P Martínez; Y Reyes; J M Milera; M V Hernández; R Torres; Y Avila; Y Barrese; C Viada; E Montero; P Hernández Journal: Clin Exp Immunol Date: 2017-11-16 Impact factor: 4.330
Authors: Cicerone Tudor; Joost te Riet; Christina Eich; Rolf Harkes; Nick Smisdom; Jessica Bouhuijzen Wenger; Marcel Ameloot; Matthew Holt; Johannes S Kanger; Carl G Figdor; Alessandra Cambi; Vinod Subramaniam Journal: J Biol Chem Date: 2014-03-24 Impact factor: 5.157